AHRQ's Clancy Details Status Of CER Institute, Opportunities For Collaboration
Executive Summary
The Agency for Healthcare Research and Quality may have to revise its role in the U.S. comparative effectiveness research arena to make room for the new independent nonprofit devoted to the field, but agency officials believe there is more than enough work to go around
You may also be interested in...
AHRQ Comparative Effectiveness Strategy Could Shift; Director Clancy Stepping Down
Carolyn Clancy, who has served as director for over 10 years, will continue on until her successor is announced, which is expected in the coming months.
Budget Continues AHRQ's Role As Leader On Comparative Effectiveness Work
The Agency for Healthcare Research and Quality's budget request for comparative effectiveness research gives the impression that, in the wake of the stalled health care reform legislation, the Obama administration is bolstering AHRQ's claim to be the lead organization for CER
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011